PARABILIS MEDICINES Stock Price, News & Analysis
Company Description
PARABILIS MEDICINES (NASDAQ: PBLS) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $3.2B, ranking #1,892 among all listed U.S. companies by market cap.
PBLS stock has declined 12.9% over the past year. Shares last traded at $27.51.
This page provides a comprehensive overview of PBLS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PARABILIS MEDICINES (PBLS) stock last traded at $27.51, down 3.16% from the previous close. Over the past 12 months, the stock has lost 12.9%. At a market capitalization of $3.2B, PBLS is classified as a mid-cap stock with approximately 117.3M shares outstanding.
PBLS Rankings
Latest News
PARABILIS MEDICINES has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include IPO, offering. View all PBLS news →
SEC Filings
PARABILIS MEDICINES has filed 5 recent SEC filings, including 4 Form 4, 1 Form SCHEDULE 13D. The most recent filing was submitted on June 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PBLS SEC filings →
Insider Radar
Insider buying activity at PARABILIS MEDICINES over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PBLS Company Profile & Sector Positioning
PARABILIS MEDICINES (PBLS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.